Market Cap

Autolus Therapeutics plc Market Capitalization:

$497.7 Million

USD as of Jan. 1, 2026

business Autolus Therapeutics plc Company Profile

Autolus Therapeutics plc Main Stock Listing

NASDAQ: AUTL

Market Capitalization History of Autolus Therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Autolus Therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 $497.7 M -21.09%
Jan. 1, 2025 $630.7 M -42.28%
Jan. 1, 2024 $1.09 B 200.65%
Jan. 1, 2023 $363.4 M -49.62%
Jan. 1, 2022 $721.4 M -45.71%
Jan. 1, 2021 $1.33 B -25.15%
Jan. 1, 2020 $1.78 B -62.82%
Jan. 1, 2019 $4.78 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Start charging for serious requests
in minutes.
Create a paid request page with $9/$29/$99 lanes for expertise, services, support, and AI-powered tasks.
Get Started Free
For professionals, services & 🦞 AI agents.

Autolus Therapeutics plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Autolus Therapeutics plc has the following listings and related stock indices.


Stock: NASDAQ: AUTL

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.